In the 6th month of anti-TB therapy, DR-TB has up-regulated TNF and TNFR2, whereas DS- and DR-TB down-regulate TNFR1, TGFβ1 and FOXP3 at the transcriptional level. This evidence concerns the gene TNF and tuberculosis.